SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000812796-08-000030
Filing Date
2008-08-14
Accepted
2008-08-14 16:50:55
Documents
5
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 DOR 10 Q FOR THE 2ND Q 2008 dor10q2q2008.htm 10-Q 615903
2 DOR CEO CERT certceo.htm EX-31.1 13170
3 DOR CFO CERT cfocert.htm EX-31.2 12934
4 DOR CEO 906 CERT ceo906cert.htm EX-32.1 7365
5 DOR CFO 906 CERT cfo906cert.htm EX-32.2 7209
  Complete submission text file 0000812796-08-000030.txt   658192
Mailing Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628
Business Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628 609-538-8200
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16929 | Film No.: 081020002
SIC: 2834 Pharmaceutical Preparations